Recent Patents on Inflammation & Allergy Drug Discovery
Title:Meet Our Editorial Board Member
Volume: 11 Issue: 1
Author(s): Alessandro Antonelli
Affiliation:
Export Options
About this article
Cite this article as:
Antonelli Alessandro , Meet Our Editorial Board Member, Recent Patents on Inflammation & Allergy Drug Discovery 2017; 11 (1) . https://dx.doi.org/10.2174/1872213X1101170817100410
DOI https://dx.doi.org/10.2174/1872213X1101170817100410 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
14
Related Articles
-
Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Current Hypertension Reviews Biphasic Vesicles for Topical Delivery of Interferon Alpha in Human Volunteers and Treatment of Patients with Human Papillomavirus Infections
Current Drug Delivery Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?
Recent Patents on Anti-Cancer Drug Discovery Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines
Current Pharmacogenomics and Personalized Medicine A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems
Current Pharmaceutical Design Macrophage Activation and HIV Infection: Can the Trojan Horse Turn into a Fortress?
Current Molecular Medicine Patent Selections:
Recent Patents on Biomarkers The Impact of Antiviral Treatments on the Course of Chronic Hepatitis C: An Evidence-Based Approach
Current Pharmaceutical Design Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation
Current Neuropharmacology The Possible Mechanisms for β-glucans to Prevent Atherosclerotic Lesions
Current Bioactive Compounds The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
Current Molecular Pharmacology Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial
Current Clinical Pharmacology Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3
Anti-Infective Agents P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease
Current Medicinal Chemistry Comparison of Pharmacodynamics and Celiac Effects of Olmesartan Medoxomil Formulations by using Olmesartan-induced Celiac-rat-model
Current Drug Delivery Anti-Immunoglobulin E Treatment with Omalizumab in Allergic Diseases an Update on Anti-Inflammatory Activity and Clinical Efficacy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Circulating Levels of Angiogenic Cytokines in Waldenstrom’s Macroglobulinemia: Clinical Correlations
Current Angiogenesis (Discontinued) The Assessment of Anxiety and Depression and its Associated Factors in SLE
Current Rheumatology Reviews Cytokines Polymorphism and mRNA Expression as Biomarkers in HCV Treatment Response
Recent Patents on Biomarkers Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents